Skip to content

Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)

Enhancing Memory Functions in Patients With Mild Cognitive Impairment by Dietary Interventions and in Combination With Exercise and Cognitive Training - Proof of Concept and Mechanisms

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01219244
Enrollment
330
Registered
2010-10-13
Start date
2010-08-31
Completion date
2016-12-31
Last updated
2017-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

memory, diet, elderly, cognition, prevention, lifestyle

Brief summary

The study will investigate whether dietary modification could provide positive effects on brain functions in elderly people with mild cognitive impairment.

Detailed description

The age-related degradation of cognitive functions even to the point of neurodegenerative disorders such as Alzheimer's disease are a growing public-health concern with devastating effects. Referring to animal data, empirical studies, and pilot human trials, dietary modification (caloric restriction, omega-3 fatty acids and resveratrol) should improve cognitive functions such as learning and memory. To test this hypothesis, the researchers study general brain functions in elderly subjects (50-80 years old) with mild cognitive impairment.

Interventions

BEHAVIORALcaloric restriction

6 months of caloric restriction (15 %)

6 months of omega-3 supplementation

6 months of resveratrol supplementation

BEHAVIORALPlacebo

6 months of placebo intake

BEHAVIORAL2nd step: intervention + physical / cognitive training

most effective dietary intervention plus physical and cognitive training

BEHAVIORAL2nd step: intervention + control

most effective dietary intervention plus control

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* subjects with mild cognitive impairment * 50-80 years old * moderate to heavy weight (BMI 25-35)

Exclusion criteria

* dementia * diabetes * severe disease * younger than 50 years * BMI \< 25

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Assessment Scale - cognitive subscalePrior to intervention and after 6 months of intervention

Secondary

MeasureTime frame
Functional/Structural brain changesPrior to intervention and after 6 months of intervention
Plasma biomarkersPrior to intervention and after 6 months of intervention

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026